The present disclosure generally relates to a medical device, and more particularly to a delivery device for automatically injecting a fluid into a target site of a subject, such as, but not limited to, the intraosseous space of a bone, after activation of the delivery device.
Every year many subjects are treated for life-threatening emergencies. Such emergencies can include shock, trauma, cardiac arrest, drug overdoses, diabetic ketoacidosis, arrhythmias, burns, and status epilepticus just to name a few. An essential element for treating many of these life threatening emergencies is rapid establishment of an IV line in order to administer drugs and fluids directly into a subject's vascular system. Whether in an ambulance by paramedics, in an emergency room by emergency specialists or on a battlefield by an Army medic, the goal is the same—quickly start an IV in order to administer lifesaving drugs and fluids. To a large degree, the ability to successfully treat most critical emergencies is dependent on the skill and luck of an operator in accomplishing vascular access. Doctors, nurses and paramedics can experience great difficulty in establishing IV access in many subjects due to a variety of causes, such as subjects with chronic disease or subjects that may not have available IV sites due to anatomical scarcity of peripheral veins, obesity, extreme dehydration or previous IV drug use. A further complicating factor in achieving IV access occurs “in the field” e.g. at the scene of an accident or military combat, or during ambulance transport where it is difficult to see the target and excessive motion makes accessing the venous system difficult.
The intraosseous (IO) space provides a direct conduit to a subject's vascular system and provides an attractive alternate route to administer IV drugs and fluids. Drugs administered intraosseously enter a subject's blood circulation system as rapidly as they do when given intravenously. In essence, bone marrow may function as a large non-collapsible vein.
Known devices capable of accessing the IO space and/or administering drugs intraosseously include, for example, the devices described in:
In addition, commercially available systems for placing needles in the IO space include the Bone Injection Gun (Persys Medical), the EZ-IO (VidaCare Corp), and the FAST1 adult intraosseous infusion system (Pyng Medical Corp.). It is desirable to improve upon these state of the art devices and provide a device that is capable of accessing and administering a fluid to the IO space at a constant rate over an extended period of time.
According to one embodiment, the present disclosure provides a delivery device adapted to deliver a fluid into an IO space of a subject at a relatively constant volumetric flow rate over an extended period of time. The delivery device may include:
(i) an outer cartridge;
(ii) an inner cartridge configured to be movably disposed in a proximal direction within the outer cartridge and configured to hold a fluid container containing the fluid;
(iii) an actuator operable to activate the delivery device;
(iv) a plunger assembly sized and configured to be movably disposed within the fluid container from a first position to a second position;
(v) an energy storage member operable to produce a force to drive the plunger assembly from the first position to the second position after activation of the delivery device;
(vi) a releasable retainer member configured to secure the plunger assembly in the first position and to release the plunger assembly after activation of the delivery device; and
(vii) a fluid delivery system having an inlet configured to be in fluid communication with an outlet of the fluid container and an outlet configured to deliver the fluid contained in the fluid container to an IO access device or IV line positioned in the IO space of the subject
wherein in operation the delivery device is activated by activating the actuator to cause a sequence of movements whereby the inner cartridge is displaced within the outer cartridge in the proximal direction and the plunger assembly is subsequently released from the retainer member and displaced from the first position to the second position by the force produced by energy storage member to force the fluid confined in the fluid container to dispense through the fluid delivery system at the relatively constant volumetric flow rate to the IO access device or IV line and to the IO space of the subject.
According to another embodiment, the present disclosure provides a device for accessing an IO space of a subject and delivering fluid to the IO space of the subject at a relatively constant volumetric flow rate over an extended period of time. In this embodiment, the delivery device may include:
(i) an outer cartridge comprising an inner coupling end and configured to hold an aspiration container;
(ii) an inner cartridge configured to be movably disposed in a proximal direction within the outer cartridge and to hold a fluid container containing the fluid, the inner cartridge comprising an aspiration plunger movably coupled to its distal end sized and configured to be movably disposed within the aspiration container;
(iii) a first actuator operable to activate the delivery device;
(iv) a plunger assembly sized and configured to be movably disposed within the fluid container from a first position to a second position;
(v) an energy storage member operable to produce a first force to drive the plunger assembly from the first position to the second position after activation of the delivery device;
(vi) a releasable retainer member configured to secure the plunger assembly in the first position and to release the plunger assembly after activation of the delivery device;
(vii) an IO access device disposed in the outer cartridge and configured to access the IO space of the subject, the IO access device comprising a second actuator operable to activate the IO access device, a tissue penetrator assembly releasably coupled to the inner coupling end of the outer cartridge and a driver operable to produce a second force to drive the tissue penetrator assembly into the IO space after activation of the IO access device; and
(viii) a fluid delivery system configured to be fluidly coupled with the outlets of the aspiration container and fluid container and coupled to the tissue penetrator assembly.
According to yet another embodiment there is provided a system. The system may include a delivery device and an IO access device. The delivery device may include:
(i) an outer cartridge comprising an aspiration container;
(ii) an inner cartridge configured to be movably disposed in a proximal direction within the outer cartridge comprising a fluid container containing a medicament and an aspiration plunger movably coupled to its distal end sized and configured to be movably disposed within the aspiration container;
(iii) a first actuator operable to activate the delivery device;
(iv) a plunger assembly sized and configured to be movably disposed within the fluid container from a first position to a second position;
(v) an energy storage member operable to produce a first force to drive the plunger assembly from the first position to the second position after activation of the delivery device;
(vi) a releasable retainer member coupled to the plunger assembly to hold the plunger assembly in the first position and configured to release the plunger assembly after activation of the delivery device; and
(vii) a catch mechanism. The IO access device is configured to be securely attached to the delivery device and may include:
(i) a housing comprising an inner coupling end;
(ii) a second actuator operable to activate the IO access device;
(iii) a tissue penetrator assembly disposed within the housing and coupled to the coupling end of the housing where the tissue penetrator assembly is configured to be released from the coupling end after activation of the IO access device;
(iv) a driver operable to produce a second force to drive the tissue penetrator assembly into the IO space after activation of the IO access device;
(v) a fluid delivery system coupled to the tissue penetrator assembly and configured to be fluidly coupled to the outlets of the aspiration container and the fluid container of the delivery device; and
(vi) an engaging lock configured to be coupled to the catch mechanism of the delivery device to secure the IO access device to the delivery device.
In still yet another embodiment, the present disclosure provides a kit comprising the delivery device described above and a fluid container containing a medicament. In other embodiments, the kit may further include an IO access device disposed within the delivery device or separate from the delivery device but configured to be securely attached to the delivery device.
According to another embodiment, there is provided a system adapted to deliver a fluid into an IO space of a subject at a relatively constant volumetric flow rate over an extended period of time. The system generally includes:
(a) a delivery device including:
(i) a fluid container having an open proximal end and a closed distal end with an orifice, the fluid container further containing the fluid;
(ii) a flow regulator comprising an inlet in fluid communication with the fluid container and an outlet;
(iii) a fluid channel in fluid communication with the outlet of the flow regulator,
(iv) a plunger assembly positioned at or near the proximal end of the fluid container and sized and configured to be movably disposed within the fluid container from a first position to a second position; and
(v) an energy storage member operable to produce a force on the plunger assembly to move the plunger assembly from the first position to the second position once activated;
(b) an IO access device comprising:
(i) a removable actuator,
(ii) a driver configured to be movably disposed from a first position to a second position when the actuator is activated,
(iii) a tissue penetrator assembly coupled to the driver and configured to access the IO space when the driver moves from the first position to the second position,
(iv) a fluid channel assembly coupled to the tissue penetrator assembly and configured to place the fluid channel assembly in fluid communication with the fluid channel when the driver moves from the first position to the second position, and
(c) an outer cartridge housing the fluid delivery system and substantially all of the IO access device
wherein in operation the IO access device is activated by activation of the actuator which moves the driver from the first position to second position allowing the tissue penetrator assembly to access the IO space and place the fluid channel in fluid communication with the fluid channel which activates the energy member to provide the force to move the plunger assembly from the first position to the second position within the fluid container and dispense the fluid through the fluid channel to the fluid channel assembly and to the IO space at the relatively constant volumetric flow rate.
The following terms shall have the following meanings:
The term “comprising” and derivatives thereof are not intended to exclude the presence of any additional component, step or procedure, whether or not the same is disclosed herein. In contrast, the term, “consisting essentially of” if appearing herein, excludes from the scope of any succeeding recitation any other component, step or procedure, except those that are not essential to operability and the term “consisting of”, if used, excludes any component, step or procedure not specifically delineated or listed. The term “or”, unless stated otherwise, refers to the listed members individually as well as in any combination.
As used herein, the term “about” generally means plus or minus 10% of the value stated. For example, about 0.5 would include 0.45 to 0.55.
The articles “a” and “an” are used herein to refer to one or to more than one (i.e. to at least one) of the grammatical objects of the article. By way of example, “a container” means one container or more than one container. The phrases “in one embodiment”, “according to one embodiment” and the like generally mean the particular feature, structure, or characteristic following the phrase is included in at least one embodiment of the present disclosure, and may be included in more than one embodiment of the present disclosure. Importantly, such phrases do not necessarily refer to the same aspect. If the specification states a component or feature “may”, “can”, “could”, or “might” be included or have a characteristic, that particular component or feature is not required to be included or have the characteristic.
As used in this specification and the appended claims, the words “proximal” and “distal” refer to directions closer to and away from, respectively, an operator (e.g., surgeon, physician, nurse, technician, etc.) of the delivery device.
The term “intraosseous space” or “IO space” refers to the spongy, cancellous bone of the epiphysis and the medullary cavity of the diaphysis, which are connected.
The term “intraosseous access device” or “IO access device” includes, but not limited to, any actuator, hollow needle, hollow drill bit, tissue penetrator assembly, fluid channel assembly, bone penetrator, catheter, cannula, trocar, inner penetrator, outer penetrator, IO needle or IO needle set and a driver operable to provide access to an IO space or interior portions of a bone. A wide variety of trocars, spindles and/or shafts may be disposed within a cannula during insertion at a selected insertion site. Such trocars, spindles and shafts may also be characterized as inner penetrators. A catheter, cannula, hollow needle or hollow drill bit may sometimes be characterized as an outer penetrator.
The term “fluid” includes any liquid, such as but not limited to, blood, water, saline solutions, IV solutions or plasma, or any mixture of liquids, particulate matter, medicament, dissolved medicament and/or drugs appropriate for injection into the IO space of a subject.
The term “container” refers to a pharmaceutically acceptable container comprising a chamber suitable to house a fluid or air. Containers can include, but are not limited to vials, barrels, ampoules or bottles and in some embodiments are made of glass, plastic, composites, laminates or metal.
The term “kit” may be used in this application to describe a wide variety of bags, containers, carrying cases and other portable enclosures which may be used to carry and store delivery devices, IO access devices and/or intravenous devices of the present disclosure along with related components and accessories. Such kits and their contents along with applicable procedures may be used to provide access to a subject's vascular system in accordance with teachings of the present disclosure.
As used herein, a “subject” may be a human or non-human mammal. Non-human mammals include, for example, livestock and pets, such as ovine, bovine, porcine, canine and feline mammals. Preferably, the subject is a human.
The term “relatively constant” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and refers without limitation to a value that, although it may change with time, does not change so substantially so as to render the value inoperative or substantially less operative. For example, maintaining a standard deviation of to within 3% or up to 5% of the mean for an hour would be considered relatively constant with respect to a volumetric flow rate.
The terms “preferred” and “preferably” refer to embodiments that may afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the present disclosure.
Embodiments of the present disclosure are generally directed to a delivery device adapted to deliver fluid into the IO space of a subject at a relatively constant volumetric flow rate over an extended period of time (i.e. at least 1 minute). In some embodiments, the fluid may be delivered to the IO space of the subject at a volumetric flow rate of about 0.5 mL/minute or about 0.6 mL/minute or about 0.7 mL/minute or about 0.8 mL/minute or about 0.9 mL/minute, or about 1.0 mL/minute, or about 1.1 mL/minute, or about 1.2 mL/minute, or about 1.3 mL/minute, or about 1.4 mL/minute, or about 1.5 mL/minute. In still other embodiments, the fluid may be delivered to the IO space of the subject at a volumetric flow rate of up to about 2 mL/min, or up to about 3 mL/min, or up to about 4 mL/min, or up to about 5 mL/min, or up to about 6 mL/min, or up to about 7 mL/min or up to about 8 mL/min or up to about 9 mL/min or up to about 10 mL/min. In other embodiments, the fluid may be delivered to the IO space of the subject at a volumetric flow rate within a range of about 0.7 mL/minute to about 1.3 mL/minute, or about 0.9 mL/minute to about 1.1 mL/minute.
In some embodiments, the delivery device may also be combined with or include an IO access device configured for insertion into the IO space and which is coupled to or configured to be coupled to or which can be decoupled from the delivery device after the IO space has been accessed by the IO access device. In other embodiments, the delivery device may be configured to fluidly connect to an IO access device already inserted at a desired area of the subject. IO access may be used as a bridge during emergency conditions until conventional IV sites can be found and used. Conventional IV sites often become available because fluids and/or medication provided via IO access may stabilize a subject and expand veins and other portions of a subject's vascular system. Accordingly, in other embodiments, the delivery device may be configured to fluidly connect to a conventional IV line already attached at a desired area of the subject.
Turning now to the drawings and in particular, to
The delivery device 1 also includes an inner cartridge 10, configured to be movably disposed within the outer cartridge 8, and may comprise an aspiration plunger 12 movably coupled to its distal end. The inner cartridge 10 is further configured to hold a fluid container 11. The fluid container 11 has an open proximal end configured to receive a plunger assembly 13 and a closed distal end comprising an orifice or outlet. The plunger assembly 13 is configured to be movably disposed within the fluid container 11. The fluid container 11 contains (i.e., is filled or partially filled with) a fluid.
The delivery device 1 also includes an energy storage member 15 operable to drive the plunger assembly 13 in a distal direction, an actuator 14 operable to activate the delivery device 1, a releasable retainer member 16 configured to secure the plunger assembly 13 and to release the plunger assembly 13 after activation of the delivery device 1 and a fluid delivery system 17 having an inlet configured to be in fluid communication with the outlet of the fluid container and the outlet of the aspiration container and an outlet configured to be fluidly connected to an IO access device or IV line positioned within the IO space of the subject. The fluid delivery system 17 may comprise a first conduit 18a fluidly coupled to the orifice or outlet of the aspiration container 9 and a second conduit 18b fluidly coupled to the orifice or outlet of the fluid container 11, and one-way valves 19a and 19b. The outlets of the one way valves 19a and 19b are fluidly coupled to form a third conduit 18c. First, second and third fluid conduits 18a, 18b and 18c may be sterile flexible tubing. Third conduit 18c in some embodiments will have just enough slack to uncoil and become taut once fluidly coupled to an IO access device.
The delivery device 1 can generally be operated by activating the actuator 14 to cause a sequence of movements whereby the inner cartridge 10, along with aspiration plunger 12, are displaced within the outer cartridge 8 in a proximal direction to aspirate third fluid conduit 18c and the plunger assembly 13 is subsequently released from the releasable retainer member 16 and displaced in a distal direction within the fluid container 11 by the energy storage member 15 to force the fluid confined in the fluid container 11 through the second tubular port to the second and third fluid conduits 18b and 18c at a relatively constant volumetric flow rate. The distal end of the third conduit 18c may be fluidly connected to an IO access device implanted into the IO space of a subject as shown in
The actuator 14 may be any suitable device for activating the delivery device 1, such as, for example, a handle, a lever, a push button, a slidable button or a trigger. Upon activation, the inner cartridge 10 is displaced within the outer cartridge 8, as indicated by arrow A in
The releasable retainer member 16 is disposed within the interior of delivery device 1 and is also configured to selectively deploy the energy storage member 15 from its first configuration to second configuration after the inner cartridge 10 has been displaced in the proximal direction from its first position to second position. The releasable retainer member 16 can be any suitable mechanism for releasably retaining the plunger assembly 13 and deploying the energy storage member 15, such as, for example, a mechanical linkage, a spring-loaded rod, a tensioned latch or tab or the like. In this manner, the operator can actuate the plunger assembly 13 by manipulating a portion of the releasable retainer member 16.
In some embodiments, the fluid in fluid container 11 comprises a medicament, such as, for example, tranexamic acid or any of the other medicaments further described below. As illustrated, the plunger assembly 13 may be moved in a distal direction, as indicated by arrow B in
The energy storage member 15 can be any device for storing energy. Thus, the energy storage member 15 may be a mechanical energy storage member, such as a spring, a device containing compressed gas, a device containing a vapor pressure-based propellant or the like. In other embodiments, the energy storage member 15 can be an electrical energy storage member, such as a battery, a capacitor, a magnetic energy storage member or the like. In yet other embodiments, the energy storage member 15 can be a chemical energy storage member, such as a container containing two substances that, when mixed, react to produce energy.
As shown, the energy storage member 15 also defines longitudinal axis L. The energy storage member 15 can be moved within the inner cartridge 10 along the longitudinal direction L between a first configuration (
With reference now to
With reference now to
According to certain embodiments of the present disclosure, the wall 23 may be rigid. According to other embodiments, the wall 23 may be flexible, whether according to the nature of the material that defines the wall 23 or according to the nature of the structure of the wall 23. The wall 23 may be made of glass, metal, or polymer, for example. In particular, polymer versions may be made of polycarbonate, polypropylene, polyethylene (such as high density polyethylene), polytetrafluoroethylene, cyclic olefin polymer, cyclic olefin copolymer, crystal zenith olefinic polymer, nylon, or engineering resins. As to flexible versions of the wall 23, butyl rubber, silicon-based rubber, latex-based rubber, coated rubber, as well as multi-layer polymer films, such as polyethylene (such as low density polyethylene) and polypropylene, may be used.
The wall 23 may have a generally cylindrical shape (although other shapes are contemplated, such as rectangular). According to some embodiments, the wall 23 may have a length of between about 70 mm to about 140 mm and defines two opposed, closed ends, proximal end 22a and distal end 22b, each having a diameter of between about 20 mm to about 50 mm. Attached to the interior surface of proximal end 22a is an inner cylindrical wall 42 having an exterior surface 42a and an interior surface 42b. Inner cylindrical wall 42, which in some embodiments may have a length of between about 10 mm to about 30 mm, defines an inner cylindrical cross-section having a closed distal end 41 comprising a cutout section 43. The closed distal end 41 therefore has a diameter that is less than the diameter for proximal end 22a and distal end 22b of wall 23. In some embodiments, the diameter of the closed distal end 41 ranges between about 20 mm to about 40 mm. The cutout section 43 is shaped and configured to engage the retainer member 34 (not shown) when the inner cartridge 24 is in the first position. For instance, the wall of the cutout section 43 may be sized and adapted to correspondingly mate with the shape of the retainer member 34 when the inner cartridge 24 in in its first position and to allow plunger assembly 33 to be movably disposed therein when the inner cartridge 24 is moved to its second position as further described below.
The exterior surface 42a of inner cylindrical wall 42 and the interior surface 23b of wall 23 are spaced apart a sufficient distance to allow the inner cartridge 24 to be movably disposed therein in a longitudinal direction L when the actuator 26 is activated.
An aspiration container mount 46 is attached to the interior surface of the distal end 22b and may be formed of the same material as the wall 23 or a different rigid solid material, such as plastic. The aspiration container mount 46 is sized and adapted to hold the aspiration container 37 (not shown) in alignment with an aspiration plunger (not shown) of inner cartridge 24. The aspiration container mount 46 further includes a notch 47 sized and adapted to receive and hold first conduit 18a.
The delivery device 20 is configured to include an aspiration container 37 disposed within the outer cartridge 22. The aspiration container 37 can be positioned on or held by the aspiration mount 46. In some embodiments, the aspiration container 37 may have a length of about 4 mm to about 12 mm. The aspiration container 37 includes an open proximal end 37a and a closed distal end 37b, each with a diameter of between about 12 mm to about 16 mm when two aspiration containers are present or between about 20 mm to about 50 mm when one aspiration container is present. The proximal end of the aspiration container 37 is sized and adapted to receive the aspiration plunger (not shown) of inner cartridge 24. The closed distal end 37b includes an orifice fluidly coupled to first conduit 18a, such as by a luer connector, threads, a snap-fit, a latch, a lock, a friction fit coupling, or any other suitable coupling features. The orifice at the closed distal end of the aspiration container 37 may have a diameter of between about 0.159 mm to about 1.6 mm. In some embodiments, the aspiration container 37 can be, for example, a glass vial.
With reference now to
Wall 51 is sized and configured to be movably disposed within outer cartridge 22 and thus may have a correspondingly similar, but smaller shape as the outer cartridge 22, such as a generally cylindrical (or rectangular) shape. According to some embodiments, wall 51 may have a length of between about 60 mm to about 140 mm and may define two opposed ends, a semi-enclosed proximal end 52a and an open distal end 52b. The semi-enclosed proximal end 52a includes an inner cylindrical wall 53, which may be rigid or flexible, attached to its interior surface. Inner cylindrical wall 53, which in some embodiments may have a length of between about 25 mm to about 45 mm, has an interior surface 53a and an exterior surface 53b and defines two opposed ends, an open proximal end 54a and a closed distal end 54b comprising a cutout section 55. The cutout section 55 is shaped and configured to prevent the plunger rod 33a (not shown) of the plunger assembly 33 from being movably disposed within the inner cartridge 24 when the inner cartridge 24 is in the first position and be movably disposed in the longitudinal direction L after the actuator 26 has been activated. For instance, the wall of the cutout section 55 may be sized and adapted to correspondingly mate with the plunger assembly 33 (not shown) when the inner cartridge 24 is in the first position. For instance, the wall of the cutout section 55 may be sized and adapted to correspondingly mate with the shape of the plunger assembly 33 when the inner cartridge 24 in in its first position and to allow plunger assembly 33 to be movably disposed therein when the inner cartridge 24 is moved to its second position as further described below.
The exterior surface 53b of inner cylindrical wall 53 and the interior surface 51b of wall 51 are spaced apart to form an inner housing 56. Inner housing 56 is sized and adapted to allow the energy storage member 31 (not shown) to be movably disposed therein from its first configuration to second configuration after activation.
Actuator 26, in the form a slide button, is attached to the exterior surface 51a of wall 51. The top surface of actuator 26 is ribbed in a direction perpendicular to the direction of actuator movement, as shown, to allow the operator's finger to engage the actuator 26 without slipping. The actuator 26 is initially in the position shown in
The releasable retainer member 34, shown in the form of one or more latch tabs 57, is fixedly attached to the interior surface of distal end 54b of inner cylindrical wall 53. The latch tabs 57 have a downwardly facing outward shoulder 57a, a downwardly facing inward shoulder 57b an upper flange 57c and a lower flange 57d. The latch tabs 57 are inherently biased outwardly, with the wall of the cutout section 43 of outer cartridge 22 being shaped and configured so as to interferingly engage downwardly facing outward shoulder 57a under force of movement of the energy storage member 31 when the delivery device 20 is in an initial position. In addition, downwardly facing inward shoulder 57b and lower flange 57c are shaped and configured to interferingly engage the plunger rod 33a (not shown) of the plunger assembly 33 when the delivery device 20 is in the initial position. With this arrangement, movement of the plunger assembly 33 in the L direction is limited due to inter engagement between the downwardly facing outward shoulder 57a of the latch tabs 57 and the cutout section 43 of outer cartridge 22 as well as by the inter engagement between downwardly facing inward shoulder 57b and lower flange 57d of the latch tabs 57 and the plunger rod 33a of plunger assembly 33. The plunger assembly 33 is thus retained before use. Once the inner cartridge 24 has moved in a proximal direction between its first position and second position (i.e. upon activation of actuator 26), latch tabs 57 will also have moved to a position within the inner cylindrical cross section defined by inner cylindrical wall 42 of outer cartridge 22 thus allowing the latch tabs 57 to spring outwards and thereby releasing the plunger assembly 33 from engagement. Additionally, once the latch tabs 57 have moved to the position within the inner cylindrical cross section defined by inner wall 42, lower flange 57d of the latch tabs 57 will now be in inter engagement with the upper surface of distal end 42c of the inner cylindrical wall 42 thereby preventing the inner cartridge 24 from being displaced in the distal direction (see
The inner cartridge 24 also includes a fluid container mount 58 sized and adapted to hold fluid container 35. The fluid container mount 58 includes an upper surface 58a for engaging the distal end of the fluid container 35 and a lower surface 58b. The fluid container mount 58 also includes an upper ring portion 58c to prevent the fluid container from moving proximally. An aspiration plunger 59 is movably coupled to the lower surface 58b of fluid container mount 58. The aspiration plunger 59 is sized and adapted to engage the inner wall of the aspiration container 37 but be movably disposed within the aspiration container 37 when the inner cartridge 24 is moved from its first position to second position. In embodiments, aspiration plunger 59 may or may not include a plug (not shown) positioned at its distal end to engage the inner sidewalls of the aspiration container 37.
The delivery device 20 is therefore configured to include a fluid container 35 disposed within the inner cartridge 24 and held by the fluid container mount 58. The fluid container 35 contains (i.e., is filled or partially filled with) a fluid. In some embodiments the amount of fluid container 35 is in the range of about 1 millilitre (mL) to about 20 mL. The fluid container 35 includes an open proximal end 35a and a closed distal end 35b comprising an orifice that is fluidly coupled to the fluid conduit 18b (not shown), such as by a luer connector, threads, a snap-fit, a latch, a lock, a friction fit coupling, or any other suitable coupling features. The fluid container 35 may have a length of between about 10 mm to about 40 mm. The proximal end 35a may have a diameter of between about 25 mm to about 40 mm and the distal end 35b may have a diameter of between about 2 mm to about 3 mm. The orifice of the distal end 35b may have a diameter of between about 0.05 mm to about 1.6 mm.
In the embodiment shown in
As shown in
A distal end portion of the plunger assembly 33 is configured to be disposed within fluid container 35. The distal end portion of the plunger assembly 33 can be coupled to and/or in contact with a plug 33c which is configured to be in fluid communication with the fluid disposed within an internal volume defined by the fluid container 35. The distal end portion of the plunger assembly 33 is configured to be movably displaced within the internal volume defined by the fluid container 35 due to the force produced by the energy storage member 31 when the energy storage member 31 moves from its first configuration to second configuration. In this manner, the energy storage member 31 acting on the plunger assembly 33 can displace the plug 33c within the fluid container 35 to expel the fluid through the orifice of distal end 35b of fluid container 35. The sidewalls of the plug 33c can be configured to contact the interior surfaces of the sidewalls of the fluid container 35 such that the plug 33c forms a fluid-tight seal with the sidewalls of the fluid container 35, for example, to prevent leakage of the fluid. The plug 33c can be made of an inert and/or biocompatible material which is rigid but soft. Example materials include rubber, silicone, plastic, polymers, any other suitable material or combination thereof. In some embodiments, the plug 33c can be monolithically formed with the plunger assembly 33.
The plunger rod 33a is attached to the proximal end of plunger 33b and includes an elongated lower member and a shaped upper member sized and configured to engage the downwardly facing inward shoulder 57b and lower surface of upper flange 57c of the latch tabs 57 when the plunger assembly 33 is in its first position. In the embodiment shown in
As described above, the fluid container 35 defines an internal volume configured to house a fluid. The fluid may comprise a medicament such as, but not limited to, an analgesic, anti-inflammatory agent, anthelmintic, anti-arrhythmic agent, antibiotic (including penicillin's), anticoagulant, antidepressant, antidiabetic agent, antiepileptic, antihistamine, antihypertensive agent, antimuscarinic agent, antimycobactefial agent, antineoplastic agent, antifibrinolytic, immunosuppressant, antithyroid agent, antiviral agent, anxiolytic sedative (hypnotics and neuroleptics), astringent, beta-adrenoceptor blocking agent, blood product and substitutes, cardiac inotropic agent, corticosteroid, cough suppressant (expectorants and mucolytics), diagnostic agent, diuretic, dopaminergic (antiparkinsonian agents), haemostatic, immunological agent, lipid regulating agent, muscle relaxant, parasympathomimetic, parathyroid calcitonin and biphosphonate, prostaglandin, radiopharmaceutical, sex hormone (including steroids), anti-allergic agent, stimulant and anorexic, sympathomimetic, thrombolytic, thyroid agent, PDE IV inhibitor, NK3 inhibitor, ppar agent, NK-2 inhibitor, CSBP/RK/p38 inhibitor, antipsychotics vasodilator and xanthine.
With reference now to
In the embodiment shown in
To illustrate operation of the delivery device 20, a sequence of events illustrating the aspiration and delivery of fluid by the device, as well as the position of the various components, is discussed progressing from
In the first configuration shown in
In the second configuration shown in
Turning now to
The IO access device 2 is configured for accessing the IO space of a subject and is coupled to the third fluid conduit 18c of the fluid delivery system 17. The IO access device 2 generally includes a tissue penetrator assembly 108 configured to penetrate a bone of the subject, a driver 104 operably coupled to the tissue penetrator assembly 108 to drive at least a portion of the tissue penetrator assembly 108 into the IO space of a subject and a second actuator 102 operable to activate the driver 104. In some embodiments, the tissue penetrator 108 may include a needle disposed within a flexible catheter such that the needle may be removed once the tissue penetrator assembly 108 has penetrated the IO space.
The IO access device 2 can generally be operated by positioning the IO access device 2 at a suitable location over a bone of a subject into which it is desired to inject a fluid. For example, the bone may be a sternum, tibia, humerus or other intraosseous injection site. Second actuator 102 may then be activated to drive tissue penetrator assembly 108 in a distal direction. The second actuator 102 may be any suitable device, such as, for example, a handle, a lever, a push button, a slidable button or a trigger. Upon activation of the second activator 102, the driver 104 is activated and the tissue penetrator assembly 108 is displaced within the outer cartridge 8, as indicated by arrow C in
The driver 104 provides power to the tissue penetrator assembly 108. The power is sufficient to penetrate the skin, muscle and bone of the subject and may be supplied to the tissue penetrator assembly 108 by any suitable means, such as, one or more of the following: a battery, a spring, compressed gas, manual force, and any other mechanical or electrical source of rotation or reciprocation. The power may also be supplied directly or indirectly (e.g. using gears) by the operator and/or the subject. In addition to batteries, electric power may come from any other suitable source including conventional wall outlets. The power source may be operably coupled with a motor. Motors may be selected from the group consisting of DC motors, AC motors, compressed gas motors, wound spring motors, and reciprocating motors. Motors may also be coupled to one or more gears, which may optionally be positioned in one or more gear boxes.
Once the IO access device 2 has moved from its first configuration to its second configuration, the delivery device 1 may be operated in a substantially similar manner as shown in
Although shown as a unitary device, in some embodiments, the IO access device 2 may be decoupled from the delivery device 1 after the IO access device has moved to its second configuration (i.e. after the tissue penetrator assembly 108 has penetrated the IO space). In such embodiments, the IO access device 2 may further include a removable base support (not shown) positioned at the distal end of the tissue penetrate assembly 108 and the fluid delivery system 17 may include a wye/tee connection (not shown). Thus, once the IO access device 2 has been decoupled from the delivery device 1, the base support will be positioned near the skin and is configured to hold the fluid delivery system 17 secure with one port of the tee connection in fluid communication with the fluid conduit 18c and a second port open.
With reference now to
With reference now to
According to certain embodiments of the present disclosure, the wall 230 may be rigid. According to other embodiments, the wall 230 may be flexible, whether according to the nature of the material that defines the wall 230 or according to the nature of the structure of the wall 230. The wall 230 may be made of glass, metal, or polymer, for example. In particular, polymer versions may be made of polycarbonate, polypropylene, polyethylene (such as high density polyethylene), polytetrafluoroethylene, cyclic olefin polymer, cyclic olefin copolymer, crystal zenith olefinic polymer, nylon, or engineering resins. As to flexible versions of the wall 230, butyl rubber, silicon-based rubber, latex-based rubber, coated rubber, as well as multi-layer polymer films, such as polyethylene (such as low density polyethylene) and polypropylene, may be used.
The wall 230 may have a generally cylindrical shape (although other shapes are contemplated, such as rectangular). According to some embodiments, the wall 230 may have a length of between about 70 mm to about 140 mm and defines two opposed, closed ends, proximal end 220a and distal end 220b, having a diameter of between about 20 mm to about 50 mm. Attached to the interior surface of proximal end 220a is an inner cylindrical wall 242 having an exterior surface 242a and an interior surface 242b. Inner cylindrical wall 242 may be rigid or flexible and in some embodiments may have a length of between 10 mm to about 30 mm, defines an inner cylindrical cross-section having a closed distal end 241 comprising a cutout section 243. The closed distal end 241 therefore has a diameter that is less than the diameter of proximal end 220a and distal end 220b. In some embodiments, the diameter of the closed distal end 241 may be about 20 mm to about 40 mm. The cutout section 243 is shaped and configured to engage the retainer member 340 (not shown) when the inner cartridge 240 is in its first position. For instance, the wall the cutout section 243 may be sized and adapted to correspondingly mate with the shape of the retainer member 340 when the inner cartridge 240 is in the first position and to allow plunger assembly 330 but be movably disposed therein when the inner cartridge is moved to its second position as further described below.
The exterior surface 242a of inner cylindrical wall 242 and the interior surface 230b of wall 230 are spaced apart a sufficient distance to allow the inner cartridge 240 to be movably disposed therein in a longitudinal direction L when the first actuator 260 is activated.
An aspiration container mount 246 is attached to the interior surface of the distal end 220b and may be formed of the same material as the wall 230 or a different rigid solid material, such as plastic. The aspiration container mount 246 is sized and adapted to hold the aspiration container 237 (not shown) in alignment with an aspiration plunger 259 (not shown) of inner cartridge 240.
The delivery device 200 is configured to include an aspiration container 370 disposed within the outer cartridge 220. The aspiration container 370 is positioned on or held by the aspiration mount 246. In some embodiments, the aspiration container 370 may have a length of about 4 mm to about 12 mm. The aspiration container 370 includes an open proximal end 370a and a closed distal end 370b with a diameter of between about 12 mm to about 16 mm when two aspiration containers are present or about 20 mm to about 50 mm when one aspiration container is present. The proximal end of the aspiration container 370 is sized and adapted to receive the aspiration plunger 259 (not shown) of inner cartridge 240. The closed distal end 370b includes an orifice fluidly coupled to the fluid delivery system 390, such as by a luer connector, threads, a snap-fit, a latch, a lock, a friction fit coupling, or any other suitable coupling features. The orifice may have a diameter of between about 0.159 mm to about 1.6 mm. In some embodiments, the aspiration container 370 can be, for example, a glass vial.
Outer cartridge 220 further includes a coupling end 450 positioned at its distal end 220b and configured to secure tissue penetrator assembly 470 in its first position during storage and to release tissue penetrator 470 upon activation of the second actuator 410 as further described below. The coupling end 450 can be any suitable mechanism for securing and deploying the tissue penetrator assembly 470, such as, for example, a mechanical linkage, a spring-loaded rod, a tensioned latch or tab or the like. In the embodiment shown in
With reference now to
Wall 251 is sized and configured to be movably disposed within outer cartridge 220 and thus may have a correspondingly similar, but smaller, shape as the outer cartridge 220, such as a generally cylindrical (or rectangular) shape. According to some embodiments, wall 251 may have a length of about 60 mm to about 140 mm and may define two opposed ends, a semi-enclosed proximal end 252a and an open distal end 252b. The semi-enclosed proximal end 252a includes an inner cylindrical wall 253, which may be rigid or flexible, attached to its interior surface. Inner cylindrical wall 253, which in some embodiments may a length of between 25 mm to about 45 mm, includes an interior surface 253a and an exterior surface 253b and defines two opposed ends, an open proximal end 254a and a closed distal end 254b comprising a cutout section 255. The cutout section 255 is shaped and configured to prevent the plunger rod 330a (not shown) of the plunger assembly 330 from being movably disposed within inner cartridge 240 when the inner cartridge 240 is in its first position and be movably disposed in the longitudinal direction L after the first actuator 260 has been activated. For instance, the wall of the cutout section 255 may be sized and adapted to correspondingly mate with the shape of the plunger assembly 330 when the inner cartridge 240 is in its first position and to allow plunger assembly 330 to be movably disposed therein when the inner cartridge 240 is moved to its second position as further described below.
The exterior surface 253b of inner cylindrical wall 253 and the interior surface 251b of wall 251 are spaced apart to form an inner housing 256. Inner housing 256 is sized and adapted to allow the energy storage member 310 (not shown) to be movably disposed therein from its first configuration to second configuration after activation.
First actuator 260, in the form a slide button, is attached to the exterior surface 251a of wall 251. The top surface of first actuator 260 is ribbed in a direction perpendicular to the direction of actuator movement, as shown, to allow the operator's finger to engage the actuator 260 without slipping. The first actuator 260 is initially in the position shown in
The releasable retainer member 340, shown in the form of one or more latch tabs 257, is fixedly attached to the interior surface of distal end 254b of inner cylindrical wall 253. The latch tabs 257 have a downwardly facing outward shoulder 257a, a downwardly facing inward shoulder 257b, an upper flange 257 and a lower flange 257d. The latch tabs 257 are inherently biased outwardly, with the wall of the cutout section 243 of outer cartridge 220 being shaped and configured so as to interferingly engage downwardly facing outward shoulder 257a under force of movement of the energy storage member 310 when the delivery device 200 is in an initial position. In addition, downwardly facing inward shoulder 257b and lower flange 257c are shaped and configured to interferingly engage the plunger rod 330a (not shown) of the plunger assembly 330 when the delivery device 200 is in the position. With this arrangement, movement of the plunger assembly 330 in the L direction is limited due to inter engagement between the downwardly facing outward shoulder 257a of the latch tabs 57 and the cutout section 243 of outer cartridge 220 as well as by the inter engagement between downwardly facing inward shoulder 257b and lower flange 257d of the latch tabs 57 and the plunger rod 330a of plunger assembly 330. The plunger assembly 330 is thus retained before use. Once the inner cartridge 240 has moved in a proximal direction from its first position to second position (i.e. upon activation of the first actuator 260), latch tabs 257 will also have moved to a position within the inner cylindrical cross-section defined by inner cylindrical wall 242 of outer cartridge 220 thus allowing the latch tabs 257 to spring outwards and thereby releasing the plunger assembly 330 from engagement. Additionally, once the latch tabs 257 have moved to the position within the inner cylindrical cross-section defined by inner wall 242, lower flange 57d of the latch tabs 57 will now be in inter engagement with the upper surface of distal end 241 of the inner cylindrical wall 242 thereby preventing the inner cartridge 240 from being displaced in the distal direction (see
The inner cartridge 240 also includes a fluid container mount 258 sized and adapted to hold fluid container 350. The fluid container mount 258 includes an upper surface 258a for engaging the distal end of the fluid container 350 and a lower surface 258b and an inner ring portion 258c. An aspiration plunger 259 is movably coupled to the lower surface 258b. The aspiration plunger 259 is sized and adapted to be movably disposed within the aspiration container 370 when the inner cartridge 240 is moved from its first position to second position. The sidewalls of the aspiration plunger 259 can be configured to contact the interior surfaces of the sidewalls of the aspiration container 370 such that the aspiration plunger 259 forms a fluid-tight seal with the sidewalls of the aspiration container 370. In some embodiments, the aspiration plunger 259 may include a plug 259a positioned at its distal end to engage the inner sidewalls of the aspiration container 370.
The delivery device 200 is therefore configured to include a fluid container 350 disposed within the inner cartridge 240 mounted on the fluid container mount 258. The fluid container 350 contains (i.e., is filled or partially filled with) a fluid. The fluid container 350 includes a proximal end 350a and a distal end 350b that is fluidly coupled to the fluid conduit 366 of fluid delivery system 390 (not shown), such as by a luer connector, threads, a snap-fit, a latch, a lock, a friction fit coupling, or any other suitable coupling features. The fluid container 350 may contain a volume of about 1 ml to about 20 mL and have a length of between about 10 mm to about 40 mm. The proximal end 350a may have a diameter of between about 25 mm to about 40 mm and the distal end 350b may have a diameter of between about 2 mm to about 3 mm. The orifice of the distal end may have a diameter of between about 0.05 mm to about 1.6 mm.
In the embodiment shown in
As shown in
A distal end portion of the plunger assembly 330 is configured to be disposed within fluid container 350. The distal end portion of the plunger assembly 330 can be coupled to and/or in contact with a plug 330c which is configured to be in fluid communication with the fluid disposed within an internal volume defined by the fluid container 350. The distal end portion of the plunger assembly 330 is configured to be movably displaced within the internal volume defined by the fluid container 350 due to the force produced by the energy storage member 310 when it moves from its first configuration to second configuration. In this manner, the energy storage member 310 acting on the plunger assembly 330 can displace the plug 330c within the fluid container 350 to expel the fluid through the orifice of distal end 350b of the fluid container 350. The sidewalls of the plug 330c can be configured to contact the interior surfaces of the sidewalls of the fluid container 350 such that the plug 330c forms a fluid-tight seal with the sidewalls of the fluid container 350, for example, to prevent leakage of the fluid. The plug 330c can be made of an inert and/or biocompatible material which is rigid but soft. Example materials include rubber, silicone, plastic, polymers, any other suitable material or combination thereof. In some embodiments, the plug 330c can be monolithically formed with the plunger assembly 330.
The plunger rod 330a is attached to the proximal end of plunger 330b and includes an elongated lower member and a shaped upper member sized and configured to engage with the downwardly facing inward shoulder 257b and lower surface of upper flange 257c of the latch tabs 257 when the plunger assembly 330 is in its first position. In the embodiment shown in
As described above, the fluid container 350 defines an internal volume configured to house a fluid. The fluid may comprise a medicament such as, but not limited to those fluids described above.
With reference now to
In the embodiment shown in
With reference again to
The IO access device 300 includes a second actuator 410 in the form of a push button. The top surface of the second actuator 410 is ribbed in a direction perpendicular to the direction of actuator movement, as shown, to allow the operator's finger to engage the second actuator 410 without slipping. The second actuator 410, configured to be directly or indirectly coupled to the coupling end of outer cartridge 220, can be activated by applying a force to the top surface of the second actuator 410 in the M direction to advance the second actuator 410 from its initial (or first position) to a second position. Movement by the second actuator 410 from its first position to second position causes a sequence of movements of the components of the IO access device 300 which move the IO access device 300 from a first configuration to a second configuration as further described below.
The IO access device 300 also includes a driver 430. According to the embodiment shown in
The tissue penetrator assembly 470 is configured to be releasably coupled to coupling end 450 of outer cartridge 220 at its proximal end and may include in various combinations a shaft, a needle, a needle set, a cannula, a trocar, a stylet or a catheter. Needles suitable for the present disclosure may be from about 30 gauge to about 10 gauge and may be sized to provide a penetration depth of between about 15 mm to about 45 mm. The tissue penetrator assembly 470 is further configured to couple to the third conduit 367 of the fluid delivery system 390 at its distal end such as described above.
To illustrate operation of the delivery device 200, a sequence of events illustrating accessing the IO space by the IO access device 300 and the aspiration and delivery of fluid by the delivery device, as well as the position of the various components, is discussed progressing from
With reference to
With reference to
In the delivery device's second configuration shown in
With reference now to
The IO access device 300 and the delivery device 200 may be connected by pressing the catch mechanism 201 to expose inner indentation, aligning the IO access device 300 and delivery device 200 and releasing the catch mechanism 201 to securely couple the engaging lock 312 and inner indentation (see
With reference now to
With reference now to
The inner cartridge 1009 has a proximal end having an opening configured to receive the plunger assembly 1013 and a distal end comprising an orifice or outlet. The plunger assembly 1013 is configured to be movably disposed within the inner cartridge 1009.
The delivery device 1000 also includes an energy storage member 1015 operable to drive the plunger assembly 1013 in a distal direction, an actuator 14 operable to activate the delivery device 1000 and a fluid delivery system 1017.
The fluid delivery system 1017 includes an inlet configured to fluidly connect to the outlet of the fluid container 1001, a seal penetrator 1018 configured to rupture the seal on the outlet of the fluid container 1001 when the fluid container is placed within the outer housing 1003, a one-way valve 1019, a flow regulator or plate 1020 and an outlet 1022 configured to fluidly connect to an IO access device or IV line positioned within the IO space of the subject by a connector, such as a luer lock. The fluid delivery system 1017 further includes a first conduit 1021a fluidly coupled between the outlet of the fluid container 1001 and inlet of the one-way valve 1019, a second conduit 1021b fluidly coupled between the outlet of the one way valve 1019 and the outlet of the inner cartridge 1009 and a third fluid conduit 1021c fluidly coupled between the regulator valve or orifice plate 1020 and outlet 1022. First, second and third fluid conduits 1021a, 1021b, 1021c may be sterile flexible tubing.
The delivery device 1000 can generally be operated by removing cap 1004 (which may be removably attached) of the outer housing 1003, placing the fluid container 1001 into the outer housing 1003 and pressing down on the fluid container 1001 to break the seal at the outlet of the fluid container 1001 via the seal penetrator 1018. In another embodiment, the cap is not removably attached, but instead may be a donut-shaped cover that guards the seal penetrator when not in use. When delivery device 1000 is in its resting state, the donut-shaped cover will be positioned at the top of the outer housing 1003 due to a force produced by the spring. When the fluid container 1001 is then pressed down towards the seal penetrator 1018, the donut-shaped cover and spring will also be pressed down, exposing the seal penetrator 1018. Accordingly, when the fluid container 1001 is subsequently removed, the donut-shaped cover can be forced back up to the top of the outer housing 1003 by the force produced by the spring to guard the seal penetrator 1018.
The delivery device 1000 can then be activated by activating the actuator 1014 to cause a sequence of movements whereby the plunger assembly 1013 is displaced within the inner cartridge 1009 in a proximal direction from its initial position to a first position to draw the fluid contained within the fluid container 1001 through the first and second conduits 1021a, 1021b and into the inner cartridge 1009. The actuator 1014 can then be subsequently released and the plunger assembly 1013 can be displaced in a distal direction within the inner cartridge 1009 from its first position to a second (or advanced) position by the energy storage member 1015 to force the fluid confined within the inner cartridge 1009 through the second fluid conduit 1021b, flow regulator or plate 1020 and third fluid conduit 1021c at a relatively constant volumetric flow rate. As discussed above, the outlet of the third conduit 1021c may be fluidly connected to an IO access device implanted into the IO space of a subject (not shown) using any known type of connector (for e.g. luer lock).
The actuator 1014 may be any suitable device for activating the delivery device 1000, such as, for example, a handle. Upon activation, a plunger rod 1013a of plunger assembly 1013 is displaced within the inner cartridge 1009, as indicated by arrow A in
Once the inner cartridge 1009 is sufficiently filled with the fluid contained within the fluid container 1001, the energy storage member 1015 can be deployed by releasing the actuator 1014. As illustrated, the plug 1013b of plunger assembly 1013 is then moved in a distal direction, as indicated by arrow B in
The energy storage member 1015, shown as a spring, also defines longitudinal axis L. The energy storage member 1015 can be moved within the inner cartridge 1009 along the longitudinal direction L between a first configuration (
The present disclosure also provides a wide variety of kits, devices and associated components which may be used to obtain vascular access to the subject. In some embodiments, such kits may include the delivery device according to the present disclosure, an IO access device, one or more connectors to communicate fluids with the subject's IO space, a fluid container containing a fluid and any combinations thereof. Such kits may also include apparatus which allows monitoring a subject.
Kits incorporating teachings of the present disclosure may be rigid, semi-rigid or soft-sided. Such kits may provide a convenient way to carry various components and devices operable to achieve vascular access in an organized and systematic fashion. Such kits may present EMS first responders and other medical personnel with a well-organized collection of components and devices to achieve vascular access by placement of IV catheters and/or IO catheters. For some embodiments, a kit incorporating teachings of the present disclosure may be combination an IV kit, an IO kit and/or a unit dose kit in one convenient bag.
With reference now to
In some embodiments, delivery device 2000 and IO access device 3000 may be operable when aligned with either the left or right collarbone and thus are operable in two different orientations.
With reference to
Continuing to refer to
With reference now to
Energy storage member 2120 may comprise any suitable means of power generation to provide a force, such as, one or more of the following: a battery, a spring, compressed gas, and any other mechanical or electrical source of rotation or reciprocation. In addition to batteries, electric power may come from any other suitable source including conventional wall outlets. The power source may be operably coupled with a motor. Motors may be selected from the group consisting of DC motors, AC motors, compressed gas motors, wound spring motors, and reciprocating motors. Motors may also be coupled to one or more gears, which may optionally be positioned in one or more gear boxes.
In some embodiments, no air will exist in interior spaces 2210d, 2210e, and 2210f, and these spaces will be pre-charged with fluid. This fluid may be a medicament or normal saline. In other embodiments, the interior spaces 2210d, 2210e, and 2210f will be filled with air.
Moving distally, outer cartridge 2101 is configured to house at least a portion of IO access device 3000 (for e.g. substantially all of IO access device except actuator 3010 which is configured to translate downwards or slidably disposed over the outer cartridge when activated) within walls 2220 and 2230. While a unitary (i.e. one-piece) wall 2220 has been illustrated in
According to certain embodiments of the present disclosure, the walls 2110, 2220, and 2230 may be rigid. According to other embodiments, the walls 2110, 2220, and 2230 may be flexible, whether according to the nature of the material that defines the walls or according to the nature of the structure of the walls. The walls 2110, 2220, and 2230 may be made of glass, metal, or polymer, for example. In particular, polymer versions may be made of polycarbonate, polypropylene, polyethylene (such as high density polyethylene), polytetrafluoroethylene, cyclic olefin polymer, cyclic olefin copolymer, crystal zenith olefinic polymer, nylon, or engineering resins. As to flexible versions of the walls 2110, 2220, and 2230, butyl rubber, silicon-based rubber, latex-based rubber, coated rubber, as well as multi-layer polymer films, such as polyethylene (such as low density polyethylene) and polypropylene, may be used.
The wall 2110 may have a generally stepped cylindrical shape (although other shapes are contemplated, such as rectangular). According to some embodiments, the wall 2110 may have a length of between about 70 mm to about 160 mm and defines two opposed, open ends, proximal end 2111a and distal end 2111b. Interior space 2210b may have a length between 60 and 100 mm. Interior space 2210c may have a length between 5 and 20 mm. Interior space 2210d may have a length between 20 and 60 mm. Interior space 2210e may have a length between 10 and 30 mm. Finally, interior space 2210f may have a length between 5 and 20 mm.
The interior spaces of wall 2110 of outer cartridge 2101 are configured to hold several parts in place. Interior space 2210b is configured to hold fluid container 2150. Interior space 2210b may be further adapted and configured to have specific mounting points for fluid container 2150 or fluid container 2150 may be adhered to the surface of space 2210b in a suitable manner. In some embodiments, fluid container 2150 does not translate relative to outer cartridge 2101 in any axis-direction. Interior space 2210c is sized and configured to hold washer 2140. Interior space 2210d is sized and configured to hold flow regulation apparatus 2131. In some embodiments, interior space 2210f is sized and configured to hold diaphragm 2160, while in others diaphragm 2160 will be located at the distal end of fluid container 2150.
As described above and referring to
Also, as described above, delivery device 2000 is configured to include flow regulator 2131. Flow regulator 2131 includes a proximal end, a distal end and a helical channel. Flow regulator 2131 is designed to form a fluid-tight seal with interior space 2210d about its diameter. Thus, fluid will only flow through helical channel and not between coils of the helix. The configuration of the helical channel can be altered to produce different head losses through flow regulator, lowering or raising the volumetric fluid flow rate of delivery device 2000. This variation in volumetric flow rate can be achieved by changing the length of the channel, or by changing the cross-sectional area of the channel. In some embodiments, the channel features a semi-elliptical cross-section, whereas in others it may feature a rectangular cross-section, a semi-circular cross-section, a triangular cross-section, or any other suitable cross-section. In one embodiment, the helical channel provides sufficient head loss and is matched to the force produced by the energy storage member 2120 such that fluid flow is maintained at a relatively low and pseudo-constant volumetric flow rate over a long duration infusion of fluid or medicament to the subject. The flow regulator 2131 may also include tubing wrapped around the helical channel (not shown).
Referring to
Base 3170 is configured to be mounted directly to outer cartridge 2101 using base mount 2260. In some embodiments, this connection is formed via a dowel system as shown in
Base 3170 is further fitted with sounding needle array 3180. Sounding needle array 3180 is configured to penetrate the skin above the manubrium first and is the first part of IO access device 3000 which contacts the manubrium during use.
Base 3170 also features a landmarking system which enables the operator to find the correct site of insertion in a repeatable fashion. The site of insertion is the manubrium. This landmarking system may feature cylindrical cut-outs that are used in tandem with the operators thumb or fingers. This landmarking system will be expanded on in step-by-step use instructions below. It may feature any other sufficient landmarking system that ensures repeatability.
Referring to
With reference now to
According to certain embodiments of the present disclosure, the wall 3090 may be rigid. According to other embodiments, the wall 3090 may be flexible, whether according to the nature of the material that defines the walls or according to the nature of the structure of the walls. The wall 3090 may be made of glass, metal, or polymer, for example. In particular, polymer versions may be made of polycarbonate, polypropylene, polyethylene (such as high density polyethylene), polytetrafluoroethylene, cyclic olefin polymer, cyclic olefin copolymer, crystal zenith olefinic polymer, nylon, or engineering resins. As to flexible versions of the wall 3090, butyl rubber, silicon-based rubber, latex-based rubber, coated rubber, as well as multi-layer polymer films, such as polyethylene (such as low density polyethylene) and polypropylene, may be used.
The wall 3090 may have a generally cylindrical shape (although other shapes are contemplated, such as rectangular). According to some embodiments, the wall 3090 may have a length between 40 mm and 70 mm on its long side, and 20 mm to 50 mm on its short side. The diameter of interior surface 3090b is designed to be slightly greater than the diameter of exterior surface 2120a.
Defined by interior surface 3090b is an inner cylindrical section 3200, having an exterior space 3200a and interior space 3200b. Exterior space 3200a is designed to match the diameter of exterior surface 2130a, allowing the inner diameter of energy storage member 3130 to fit concentrically around it. Interior space 3200b is designed to hold driver 3140 in place and translate with it as it moves from the first position to the second position.
In some embodiments, interior surface 3090b is directly adhered to energy storage member 3130. In other embodiments, energy storage member 3130 is mounted to second actuator 3010 in another suitable manner. This allows for energy storage member 3130 to exert a force on second actuator 3010 until the actuator is removed.
Second actuator 3010, energy storage member 3130 and driver 3140 allow for transmission of operator force from the hand to the tissue penetrator assembly and insertion of the tissue penetrator assembly into the IO space. During operation, energy storage member 3130 acts to counteract the applied operator force to ensure that deployment of tissue penetrator assembly 3150 does not occur before IO access device 3000 contacts the manubrial surface via sounding needle array 3180. This will be expanded on further in subsequent step-by-step discussions of the operation of delivery device 2000. Energy storage member 3130 may comprise any suitable means of power generation, such as, one or more of the following: a battery, a spring, compressed gas, and any other mechanical or electrical source of rotation or reciprocation. In addition to batteries, electric power may come from any other suitable source including conventional wall outlets. The power source may be operably coupled with a motor. Motors may be selected from the group consisting of DC motors, AC motors, compressed gas motors, wound spring motors, and reciprocating motors. Motors may also be coupled to one or more gears, which may optionally be positioned in one or more gear boxes.
Second actuator 3010 is a removable feature with multiple opposing forces holding it in place until removal is desired. The first force on second actuator 3010 stems from energy storage member 3130 which exerts an upward force in the positive z-direction. Two reactionary forces from the interaction of catches 3090c and 3090d with rails 2120c and 2120d provide the opposing force in the negative z-direction. After accessing the IO space, the operator applies a torque to second actuator 3010. This allows both catches to translate along their rails until they are released. The release of catches 3090c and 3090d from rails 2120c and 2120d removes the force opposing energy storage member 3130 allowing the energy storage member to exert an upward force on the second actuator 3010 to remove the second actuator 3010 from the IO access device 3000.
To illustrate operation of the delivery device 2000, a sequence of events illustrating accessing the IO space by the IO access device 3000 and then delivery of fluid by delivery device 2000, as well as the position of various components, is discussed and depicted in
Continuing on, plunger assembly 2121 is in a first position, where the plunger tip is mounted concentrically within fluid container 2150. In some embodiments, the fluid pathway from fluid container 2150 to fluid channel assembly 3160 is pre-charged with fluid, whereas in others it will be pre-charged with air. For this discussion, it be assumed to be pre-charged with fluid, such as a medicament. Diaphragm 2160 is in its closed configuration and awaiting to be opened with a sufficient pressure differential created by movement of plunger assembly 2121. Energy storage member 2120 is at its most compressed state and providing a constant force on plunger assembly 2121. Movement of plunger assembly 2121 is restricted due to back pressure created by the interaction of fluid channel assembly 3160 and distal end of the delivery device. Once this interaction is broken after driver 3140 pushes fluid channel assembly 3160 in the negative z-direction, plunger assembly 2121 will be allowed to translate towards its second position and fluid or medicament will be able to flow from the fluid container 2150 to the fluid channel assembly 3160.
With reference to
With reference to
With reference to
With reference to
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 62/930,276 filed on Nov. 4, 2019. The contents of the aforementioned application are incorporated by reference herein.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CA2020/051495 | 11/4/2020 | WO |
Number | Date | Country | |
---|---|---|---|
62930276 | Nov 2019 | US |